GÜMÜŞLÜ, S. 2012. Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy. 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , (Geneva, Switzerland), 294.

GÜMÜŞLÜ, S., (2012). Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy . 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) (pp.294). Geneva, Switzerland

GÜMÜŞLÜ, SAADET. "Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy," 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Geneva, Switzerland, 2012

GÜMÜŞLÜ, SAADET. "Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, pp.294, 2012

GÜMÜŞLÜ, S. (2012) . "Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, p.294.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Soluble TRAIL levels in patients with allergic rhinoconjunctivitis: effect of immunotherapy}, congress name={31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={294} }